Weijian Zhu

Weijian Zhu

Auto-generated profile, based on publicly available information

Weijian Zhu

The First Clinical Medical College, Gannan Medical University, Ganzhou, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LLLifang Luo
Lifang Luo
WSWenjing Sun
Wenjing Sun
WZWeijian Zhu
Weijian Zhu
SLShuhan Li
Shuhan Li
WZWenqi Zhang
Wenqi Zhang
YZYihu Zheng
Yihu Zheng
Cisplatin is one of the most effective chemotherapy drugs and is widely used in the treatment of cancer, including hepatocellular carcinoma (HCC) and cervical cancer, but its therapeutic benefit is limited by the development of resistance. Our previous studies demonstrated that BCAT1 promoted cell proliferation and decreased cisplatin sensitivity in HCC cells. However, the exact role and mechanism of how BCAT1 is involved in cisplatin cytotoxicity remain undefined. In this study, we revealed that cisplatin triggered autophagy in cancer cells, with an increase in BCAT1 expression. The cisplatin-induced up-regulation of BCAT1 decreased the cisplatin sensitivity by regulating autophagy through the mTOR signaling pathway. In addition, branched-chain amino acids or leucine treatment inhibited cisplatin- or BCAT1-mediated autophagy and increased cisplatin sensitivity by activating mTOR signaling in cancer cells. Moreover, inhibition of autophagy by chloroquine increased cisplatin sensitivity in vivo. Also, the knockdown of BCAT1 or the administration of leucine activated mTOR signaling, inhibited autophagy, and increased cisplatin sensitivity in cancer cells in vivo. These findings demonstrate a new mechanism, revealing that BCAT1 decreases cisplatin sensitivity in cancer cells by inducing mTOR-mediated autophagy via branched-chain amino acid leucine metabolism, providing an attractive pharmacological target to improve the effectiveness of chemotherapy.

1 June 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
XSXuecheng Sun
Xuecheng Sun
FLFeiyan Lin
Feiyan Lin
WSWenjing Sun
Wenjing Sun
WZWeijian Zhu
Weijian Zhu
DFDaoquan Fang
Daoquan Fang
LJLei Jiang
Lei Jiang
Exosomal microRNA (miRNA) secretion has been characterized as a vital factor in intercellular communication among cancer cells. However, little is known about cancer-secreted miRNAs specifically involved in metastasis of colorectal cancer (CRC). Here, we found that exosomes derived from metastatic CRC cell line SW620 promoted migration, invasion, and epithelial-mesenchymal transition (EMT) of CRC cells. The profiling of exosome miRNAs revealed that microRNA (miR)-335-5p was highly expressed in exosomes from metastatic SW620 cells compared to those derived from primary SW480 cells. miR-335-5p was transmitted from metastatic SW620 cells to CRC cells via exosomes and promoted migration, invasion, and EMT of CRC cells. Moreover, exosome-transmitted miRNA-335-5p promotes CRC cell invasion and metastasis by facilitating EMT via targeting RAS p21 protein activator 1 (RASA1). Overexpression of RASA1 abolished the promotive effects of exosomal miR-335-5p on CRC cell migration, invasion, and EMT. Collectively, our data revealed that exosomal miR-335-5p derived from metastatic CRC cells promotes CRC cell invasion and metastasis by facilitating EMT via targeting RASA1, which may serve as a potential therapeutic target for CRC metastasis.

1 January 2024 in Cancer Control
Verified
Journal Article
Open access
JWJiaqi Wang
Jiaqi Wang
XOXinting Ouyang
Xinting Ouyang
WZWeijian Zhu
Weijian Zhu
QYQiang Yi
Qiang Yi
JZJinhua Zhong
Jinhua Zhong
Chemokine ligand 11 is a member of the CXC chemokine family and exerts its biological function mainly through binding to CXCR3 and CXCR7. The CXCL11 gene is ubiquitously overexpressed in various human malignant tumors; however, its specific mechanisms vary among different cancer types. Recent studies have found that CXCL11 is involved in the activation of multiple oncogenic signaling pathways and is closely related to tumorigenesis, progression, chemotherapy tolerance, immunotherapy efficacy, and poor prognosis. Depending on the specific expression of its receptor subtype, CXCL11 also has a complex 2-fold role in tumours; therefore, directly targeting the structure-function of CXCL11 and its receptors may be a challenging task. In this review, we summarize the biological functions of CXCL11 and its receptors and their roles in various types of malignant tumors and point out the directions for clinical applications.

4 March 2022 in Fertility and Sterility
Verified
Journal Article
Closed access
WZWeijian Zhu
Weijian Zhu
LJLei Jiang
Lei Jiang
YLYan Li
Yan Li
JSJunhui Sun
Junhui Sun
CLChunchun Lin
Chunchun Lin
WNWuhua Ni
Wuhua Ni